126 related articles for article (PubMed ID: 35131377)
1. Time-varying risk associations of renin angiotensin system inhibitors with pneumonia and related deaths in a cohort of 252,616 patients with diabetes (2002-2019).
Yang A; Shi M; Wu H; Lau ES; Fan B; Kong AP; Ma RC; Luk AO; Chan JC; Chow E
Diabetes Res Clin Pract; 2022 Mar; 185():109233. PubMed ID: 35131377
[TBL] [Abstract][Full Text] [Related]
2. Effects of RAS inhibitors on all-site cancers and mortality in the Hong Kong diabetes surveillance database (2002-2019).
Yang A; Wu H; Lau ESH; Shi M; Fan B; Kong AP; Ma RC; Luk AO; Chan JC; Chow E
EBioMedicine; 2022 Sep; 83():104219. PubMed ID: 35970023
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcomes following discontinuation of renin-angiotensin-system inhibitors in patients with type 2 diabetes and advanced chronic kidney disease: A prospective cohort study.
Yang A; Shi M; Lau ESH; Wu H; Zhang X; Fan B; Kong APS; Luk AOY; Ma RCW; Chan JCN; Chow E
EClinicalMedicine; 2023 Jan; 55():101751. PubMed ID: 36457651
[TBL] [Abstract][Full Text] [Related]
4. Association between renin-angiotensin-aldosterone system blockade and clinical outcomes in patients with hypertension: real-world observation from a nationwide hypertension cohort.
Park CS; Kim B; Rhee TM; Lee HJ; Lee HS; Park JB; Kim YJ; Han KD; Kim HK
Clin Res Cardiol; 2023 Nov; 112(11):1577-1586. PubMed ID: 36867200
[TBL] [Abstract][Full Text] [Related]
5. Renin-angiotensin system modulation and outcomes in patients hospitalized for interstitial SARS-CoV2 pneumonia: a cohort study.
Landolfo M; Maino A; Di Salvo E; Fiorini G; Peterlana D; Borghi C
Intern Emerg Med; 2022 Aug; 17(5):1335-1341. PubMed ID: 35064437
[TBL] [Abstract][Full Text] [Related]
6. Renin-angiotensin system inhibitors and risk of fractures: a prospective cohort study and meta-analysis of published observational cohort studies.
Kunutsor SK; Blom AW; Whitehouse MR; Kehoe PG; Laukkanen JA
Eur J Epidemiol; 2017 Nov; 32(11):947-959. PubMed ID: 28752198
[TBL] [Abstract][Full Text] [Related]
7. Effects of renin-angiotensin system inhibitor type and dosage on survival after transcatheter aortic valve implantation.
Fischer-Rasokat U; Bänsch C; Renker M; Rolf A; Charitos EI; Weferling M; Liebetrau C; Herrmann E; Choi YH; Hamm CW; Kim WK
Eur Heart J Cardiovasc Pharmacother; 2022 Dec; 8(8):815-824. PubMed ID: 35441662
[TBL] [Abstract][Full Text] [Related]
8. Comparative risk for angioedema associated with the use of drugs that target the renin-angiotensin-aldosterone system.
Toh S; Reichman ME; Houstoun M; Ross Southworth M; Ding X; Hernandez AF; Levenson M; Li L; McCloskey C; Shoaibi A; Wu E; Zornberg G; Hennessy S
Arch Intern Med; 2012 Nov; 172(20):1582-9. PubMed ID: 23147456
[TBL] [Abstract][Full Text] [Related]
9. Influence of Renin-Angiotensin System Inhibitors on Lower-Respiratory Tract Infections in Type 2 Diabetes: The Fremantle Diabetes Study Phase II.
Davis TME; Davis WA
Diabetes Care; 2020 Sep; 43(9):2113-2120. PubMed ID: 32616610
[TBL] [Abstract][Full Text] [Related]
10. Impact of renin-angiotensin system inhibitors on the survival of patients with rectal cancer.
Zeman M; Skałba W; Wilk AM; Cortez AJ; Maciejewski A; Czarniecka A
BMC Cancer; 2022 Jul; 22(1):815. PubMed ID: 35879682
[TBL] [Abstract][Full Text] [Related]
11. Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With COVID-19 Diagnosis and Mortality.
Fosbøl EL; Butt JH; Østergaard L; Andersson C; Selmer C; Kragholm K; Schou M; Phelps M; Gislason GH; Gerds TA; Torp-Pedersen C; Køber L
JAMA; 2020 Jul; 324(2):168-177. PubMed ID: 32558877
[TBL] [Abstract][Full Text] [Related]
12. Antihypertensive drugs and risk of cancer: network meta-analyses and trial sequential analyses of 324,168 participants from randomised trials.
Bangalore S; Kumar S; Kjeldsen SE; Makani H; Grossman E; Wetterslev J; Gupta AK; Sever PS; Gluud C; Messerli FH
Lancet Oncol; 2011 Jan; 12(1):65-82. PubMed ID: 21123111
[TBL] [Abstract][Full Text] [Related]
13. Patients with hypertension hospitalized with COVID-19 pneumonia using angiotensinconverting enzyme inhibitors and angiotensin II receptor blockers or other antihypertensives: retrospective analysis of 435 patients.
Baslilar S; Saylan B
Ann Saudi Med; 2021; 41(5):268-273. PubMed ID: 34618609
[TBL] [Abstract][Full Text] [Related]
14. The impact of Renin-Angiotensin System Inhibitors on bone fracture risk: a nationwide nested case-control study.
Kim KM; Hwang EJ; Lee S; Yoon JH
BMC Musculoskelet Disord; 2024 Jan; 25(1):3. PubMed ID: 38166774
[TBL] [Abstract][Full Text] [Related]
15. Renin-angiotensin system inhibition is not associated with increased sudden cardiac death, cardiovascular mortality or all-cause mortality in patients with aortic stenosis.
Bang CN; Greve AM; Køber L; Rossebø AB; Ray S; Boman K; Nienaber CA; Devereux RB; Wachtell K
Int J Cardiol; 2014 Aug; 175(3):492-8. PubMed ID: 25012498
[TBL] [Abstract][Full Text] [Related]
16. Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Death in Patients Hospitalised with COVID-19: A Retrospective Italian Cohort Study of 43,000 Patients.
Trifirò G; Massari M; Da Cas R; Menniti Ippolito F; Sultana J; Crisafulli S; Giorgi Rossi P; Marino M; Zorzi M; Bovo E; Leoni O; Ludergnani M; Spila Alegiani S;
Drug Saf; 2020 Dec; 43(12):1297-1308. PubMed ID: 32852721
[TBL] [Abstract][Full Text] [Related]
17. The association between renin angiotensin aldosterone system blockers and future osteoporotic fractures in a hypertensive population - A population-based cohort study in Taiwan.
Kao YT; Huang CY; Fang YA; Liu JC
Int J Cardiol; 2020 Apr; 305():147-153. PubMed ID: 31955975
[TBL] [Abstract][Full Text] [Related]
18. Comparative Effectiveness of Combination Therapy with Statins and Angiotensin-Converting Enzyme Inhibitors versus Angiotensin II Receptor Blockers in Patients with Coronary Heart Disease: A Nationwide Population-Based Cohort Study in Korea.
Lee J; Lee S
Pharmacotherapy; 2018 Nov; 38(11):1095-1105. PubMed ID: 30225928
[TBL] [Abstract][Full Text] [Related]
19. Association between angiotensin-converting enzyme inhibitors or angiotensin receptor blockers and community-acquired pneumonia: A nationwide population propensity-score matching study.
Lin SY; Chang SS; Lin CL; Lin CC; Hsu WH; Chou CH; Chi CY; Lin CD; Tu CY; Hsu CY; Kao CH
Int J Clin Pract; 2021 Oct; 75(10):e14476. PubMed ID: 34107133
[TBL] [Abstract][Full Text] [Related]
20. Risk of Viral Infection in Patients Using Either Angiotensin-converting Enzyme Inhibitors or Angiotensin Receptor Blockers: A Nationwide Population-based Propensity Score Matching Study.
Lin SY; Ju SW; Lin CL; Lin CC; Hsu WH; Chou CH; Chi CY; Hsu CY; Kao CH
Clin Infect Dis; 2020 Dec; 71(10):2695-2701. PubMed ID: 32504531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
